Rudy Li
Stock Analyst at Chardan Capital
(4.89)
# 53
Out of 5,143 analysts
28
Total ratings
81.25%
Success rate
96.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $30 | $24.65 | +21.70% | 4 | Jan 2, 2026 | |
| DRUG Bright Minds Biosciences | Maintains: Buy | $80 | $90.39 | -11.49% | 3 | Jan 2, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $80 → $330 | $304.38 | +8.42% | 3 | Oct 17, 2025 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $55 | $42.24 | +30.21% | 4 | Oct 7, 2025 | |
| IMUX Immunic | Initiates: Buy | $3 | $0.69 | +335.79% | 1 | Sep 29, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $15 | $17.18 | -12.69% | 1 | Sep 29, 2025 | |
| RVPH Reviva Pharmaceuticals Holdings | Initiates: Buy | $2 | $0.34 | +494.18% | 1 | Sep 29, 2025 | |
| PRTA Prothena Corporation | Maintains: Buy | $18 | $10.34 | +74.08% | 7 | Aug 28, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $24 | $30.05 | -20.13% | 4 | Aug 13, 2025 |
Centessa Pharmaceuticals
Jan 2, 2026
Maintains: Buy
Price Target: $30
Current: $24.65
Upside: +21.70%
Bright Minds Biosciences
Jan 2, 2026
Maintains: Buy
Price Target: $80
Current: $90.39
Upside: -11.49%
Praxis Precision Medicines
Oct 17, 2025
Maintains: Buy
Price Target: $80 → $330
Current: $304.38
Upside: +8.42%
Xenon Pharmaceuticals
Oct 7, 2025
Maintains: Buy
Price Target: $55
Current: $42.24
Upside: +30.21%
Immunic
Sep 29, 2025
Initiates: Buy
Price Target: $3
Current: $0.69
Upside: +335.79%
Alto Neuroscience
Sep 29, 2025
Initiates: Buy
Price Target: $15
Current: $17.18
Upside: -12.69%
Reviva Pharmaceuticals Holdings
Sep 29, 2025
Initiates: Buy
Price Target: $2
Current: $0.34
Upside: +494.18%
Prothena Corporation
Aug 28, 2025
Maintains: Buy
Price Target: $18
Current: $10.34
Upside: +74.08%
Stoke Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $24
Current: $30.05
Upside: -20.13%